All biotech translators on our team hold advanced degrees (MSc or PhD) in molecular biology, biochemistry, cell biology, protein chemistry, bioinformatics, or a related discipline. Many have direct laboratory research experience at academic institutions or biotech companies. We do not use general science translators for complex biotechnology documents — the scientific depth required demands specialist expertise.
Biotechnology & Research
Biotechnology & ResearchTranslation Services
Day Translations provides expert translation services for biotechnology companies, academic research institutions, and life sciences R&D organizations — covering research publications, patent applications, grant proposals, laboratory protocols, and regulatory filings in 500+ languages.
ISO 17100 CertifiedR&D · Patent · PublicationsBiotech Specialists
ISO 27001 information security · HIPAA-aligned · GSA-approved vendor
0+
Biotech Documents
0+
Years
0+
Biotech Clients
0%
Accuracy Rate
Our Services
Specialized translation for biotechnology & research.
Specialized translation for every document type in the biotechnology & research sector.
Research Pubs
Scientific Research Publications
Translation of peer-reviewed research articles, preprints, and conference papers for international publication in high-impact biotechnology and life sciences journals.
Patents
Biotechnology Patent Applications
Translation of biotech patent applications for USPTO, EPO, WIPO (PCT), and JPO, including sequence listings, claims, specifications, and prior art searches.
Grant Proposals
Research Grant Proposals
Translation of NIH, ERC, Horizon Europe, and other research grant applications, including scientific narratives, specific aims, and supporting documentation.
Lab Protocols
Laboratory Protocols & Methods
Translation of laboratory protocols, experimental methods, SOPs, and research materials for international research collaborations and multi-site studies.
Regulatory
Biotech Regulatory Filings
IND, CTA, and BLA filings for biologic products, including manufacturing process descriptions, analytical methods, and preclinical safety data.
Licensing
Technology Transfer & Licensing
Translation of licensing agreements, technology transfer documentation, material transfer agreements (MTAs), and research collaboration contracts.
Clinical Data
Clinical & Preclinical Data
Translation of preclinical study reports, toxicology studies, pharmacokinetic data, and Phase I–III clinical data packages for regulatory submissions.
Investor Comms
Investor & Corporate Communications
Translation of investor presentations, annual reports, press releases, and corporate communications for biotech companies operating in global capital markets.
Regulatory Compliance
Built for global regulatory requirements.
Every translation is designed to meet the specific requirements of the target regulatory authority.
FDA 21 CFR Part 312
IND Regulations
FDA regulations governing Investigational New Drug applications for biologic products, including requirements for manufacturing, preclinical, and clinical data.
EMA ATMP Guidelines
Advanced Therapy Medicinal Products
EMA guidelines for advanced therapy medicinal products including gene therapy, somatic cell therapy, and tissue-engineered products developed by biotech companies.
USPTO/EPO Patent Rules
Patent Translation Requirements
Patent translation requirements for USPTO, EPO, WIPO PCT, and JPO — including sequence listing format requirements (ST.25/ST.26) for biotechnology patents.
NIH Grants Policy
Research Grant Compliance
NIH Grants Policy Statement requirements for grant applications and reporting, applicable to translated grant proposals and research reports.
ICH Q5A–Q5E
Biotechnology Quality Guidelines
ICH quality guidelines for biotechnological products covering viral safety, stability, characterization, and comparability — applicable to biologic regulatory submissions.
ISO 17100:2015
Translation Quality Standard
All biotech translations produced under ISO 17100 processes with qualified scientific translator, independent reviewer, and project manager.
Why Day Translations
The biotechnology & research partner trusted globally.
Biotechnology translation demands the deepest level of scientific expertise in the life sciences language services industry. The documents produced by biotech companies — from patent applications describing novel molecular mechanisms to regulatory filings for biologic drugs — require translators who are not just linguistically skilled but scientifically qualified. Day Translations has assembled a team of biotech translators who hold PhDs and advanced degrees in molecular biology, biochemistry, cell biology, protein chemistry, and related disciplines.
Patent translation is one of the most critical services in our biotech practice. A biotech patent application must be translated with absolute precision — the scope of patent protection depends on the exact wording of the claims, and a mistranslation can render a patent unenforceable or expose a company to infringement liability. Day Translations employs patent translators who combine scientific expertise with knowledge of patent law in the target jurisdiction, ensuring that claims, specifications, and sequence listings are translated with the precision required for IP protection.
For biotech companies seeking international research funding, Day Translations provides grant proposal translation services for NIH, ERC, Horizon Europe, and other major research funding agencies. Our grant translators understand the specific requirements of each funding agency — the NIH Specific Aims format, the ERC Scientific Excellence criteria, the Horizon Europe impact assessment framework — and produce translations that communicate the scientific vision and potential impact of the proposed research with the clarity and persuasiveness required for competitive grant applications.
Technology transfer and research collaboration represent another important area of our biotech translation practice. As biotech companies increasingly operate in global research ecosystems — licensing technologies to international partners, conducting multi-site studies with academic collaborators, and entering into cross-border joint ventures — the need for precise translation of licensing agreements, material transfer agreements, and research collaboration contracts has grown significantly. Day Translations provides legal-scientific translation services that bridge the gap between scientific content and legal precision.
Key Capabilities
- PhD-level biotech scientific translation
- Biotechnology patent applications (USPTO/EPO/PCT/JPO)
- Sequence listing translation (ST.25/ST.26)
- NIH, ERC, and Horizon Europe grant proposals
- IND/CTA/BLA for biologic products
- Technology transfer and licensing agreements
- Preclinical study report translation
- Research collaboration and MTA translation
Who We Serve
Serving the full biotechnology & research ecosystem.
Biotech Companies
Early-stage and established biotechnology companies requiring translation for patent protection, regulatory filings, investor communications, and research collaborations.
- Biotech patent applications
- IND/CTA/BLA regulatory filings
- Investor presentation translation
- Technology licensing agreements
- Research collaboration contracts
Academic Research Institutions
Universities, research institutes, and academic medical centers requiring translation for international publications, grant applications, and research collaborations.
- Research publication translation
- Grant proposal translation
- Research collaboration agreements
- Conference abstract translation
- Technology transfer documentation
Life Sciences Investors
Venture capital firms, private equity, and investment banks requiring translation for due diligence, portfolio company communications, and deal documentation.
- Due diligence documentation
- Portfolio company translation
- Investment memoranda
- Term sheet and deal documentation
- Investor reporting translation
Our Process
Six-step biotech translation process.
01
Scientific Domain Assessment
PhD-level specialist reviews document type, scientific discipline, and regulatory context to assign translators with matching research expertise.
02
Scientific Terminology Setup
Discipline-specific terminology database established, patent claim terminology reviewed, and sequence listing format verified.
03
Expert Scientific Translation
PhD-qualified translator with direct research experience produces translation with full scientific accuracy.
04
Independent Scientific Review
Second qualified scientist-linguist independently reviews for scientific accuracy, terminology consistency, and regulatory compliance.
05
Legal/Patent Review (if applicable)
For patent applications, patent-qualified reviewer verifies claim scope, specification consistency, and sequence listing accuracy.
06
Certified Delivery
Final document delivered with Certificate of Translation, full audit trail, and terminology database for future related documents.
FAQ
Frequently asked questions.
Yes. Biotechnology patent translation is a core service. Our biotech patent translators combine scientific expertise with knowledge of patent law in the target jurisdiction. We translate patent applications for USPTO, EPO, WIPO (PCT), and JPO, including claims, specifications, drawings, and sequence listings in ST.25 and ST.26 format. We also translate prior art searches, freedom-to-operate analyses, and patent prosecution correspondence.
Yes. We translate research grant proposals for NIH, ERC, Horizon Europe, CIHR, and other major research funding agencies. Our grant translators understand the specific requirements of each funding agency and produce translations that communicate the scientific vision and potential impact of the proposed research with the clarity and persuasiveness required for competitive applications.
We translate sequence listings in both ST.25 (legacy) and ST.26 (current WIPO standard) formats. Our sequence listing specialists verify that all sequence identifiers, feature annotations, and organism designations are accurately translated and formatted according to the applicable standard. We also provide sequence listing conversion services (ST.25 to ST.26) as required by WIPO from January 2022.
Yes. We translate preclinical study reports including toxicology studies, pharmacokinetic studies, pharmacology studies, and safety pharmacology studies for IND, CTA, and BLA submissions. Our preclinical translators hold advanced degrees in pharmacology, toxicology, or related disciplines and understand the specific GLP study report format required by FDA and ICH guidelines.
Yes. We provide legal-scientific translation services for technology licensing agreements, material transfer agreements (MTAs), research collaboration agreements, and joint development agreements. Our translators combine scientific expertise with legal translation skills to ensure that both the scientific content and the legal terms are accurately translated.
Standard biotech patent translations are typically delivered within 7–14 business days depending on length and complexity. Expedited turnaround (3–5 business days) is available for urgent filings. For PCT national phase entries with multiple language requirements, we can deliver all languages simultaneously using parallel translation teams.
Yes. We translate investor presentations, annual reports, press releases, and corporate communications for biotech companies operating in global capital markets. Our investor communications translators combine scientific expertise with financial communication skills to ensure that complex scientific information is accurately and compellingly communicated to international investors.
Ready to advance your biotechnology & research program?
Contact our biotechnology & research translation specialists. We respond within 15 minutes during business hours.
Explore More
Related life sciences services.
Biotechnology and research are one part of the life sciences spectrum. Day Translations supports the full drug development, regulatory, and scientific lifecycle.
Pharma
Pharmaceutical & Biotech Translation
IND, NDA, BLA, CTD dossiers, drug labeling, and pharmacovigilance reports.
Genomics
Genomics & Precision Medicine
NGS protocols, gene therapy filings, companion diagnostics, and biomarker studies.
Regulatory
Regulatory Affairs Translation
CTD/eCTD dossiers, health authority correspondence, and risk management plans.
As Featured In
